| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/18/2009 | EP1919477A4 Method of improving wakefulness |
| 03/18/2009 | EP1888514B1 Salts of substituted allophanates and their use in drugs |
| 03/18/2009 | EP1845797B1 Food products comprising hydrolysed milk solids with improved taste |
| 03/18/2009 | EP1824486B1 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 03/18/2009 | EP1819366B1 A staining composition for staining an ophthalmic membrane |
| 03/18/2009 | EP1805129B1 (biphenyl) carboxylic acids and derivatives thereof |
| 03/18/2009 | EP1802311B1 4-aminophenyl morpholinone derivatives for the treatment of hepatitis c |
| 03/18/2009 | EP1782802B1 Combined use of pterostilbene and quercetin for the production of cancer treatment medicaments |
| 03/18/2009 | EP1768945B1 Substituted hydroxyacetophenon derivatives |
| 03/18/2009 | EP1765807B1 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation |
| 03/18/2009 | EP1713466B1 Antiparasitic composition containing an organic amine salt of closantel |
| 03/18/2009 | EP1689380A4 Method for treating adamts-5-associated disease |
| 03/18/2009 | EP1677627B1 Dietetic preparation with hyaluronate for treatment of osteoporosis |
| 03/18/2009 | EP1663987B1 Ophthalmic compositions for treating ocular hypertension |
| 03/18/2009 | EP1658289B1 3-substituted imidazopyridine-derivatives as c-kit inhibitors |
| 03/18/2009 | EP1656346B1 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases |
| 03/18/2009 | EP1641803B1 Thienopyrimidine derivatives as potassium channel inhibitors |
| 03/18/2009 | EP1615921B1 Pyrido 2,3-d pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 03/18/2009 | EP1615629B1 Peptide deformylase inhibitors |
| 03/18/2009 | EP1613328B1 Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
| 03/18/2009 | EP1575960B1 1,4-diazabicyclo 3.2.2 nonanecarboxamide derivatives, preparation and therapeutic use thereof |
| 03/18/2009 | EP1567493B1 Phenyl substituted piperidine compounds for use as ppar activators |
| 03/18/2009 | EP1546103B1 Piperazine and piperidine derivatives for treatment of neurological diseases |
| 03/18/2009 | EP1539151B1 Biaryl compounds having anti-infective activity |
| 03/18/2009 | EP1530455B1 A pharmaceutical formulation and its use in the treatment of inner ear diseases |
| 03/18/2009 | EP1513806B1 Sulphonic acid salts of mandelic acid derivatives |
| 03/18/2009 | EP1501846B1 Tricyclic macrolide antibacterial compounds |
| 03/18/2009 | EP1495763B1 Therapeutic cream for dermatitis |
| 03/18/2009 | EP1458720B1 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1439758B1 Non-lauric, non-trans, non-temper fat compositions |
| 03/18/2009 | EP1399499B1 Agent for the prevention and treatment of sexually transmitted diseases-i |
| 03/18/2009 | EP1389096B1 Delivery of opioids through an inhalation route |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP1377273B1 Method for producing an isoflavone concentrate |
| 03/18/2009 | EP1353624B1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 03/18/2009 | EP1333816B1 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same |
| 03/18/2009 | EP1292316B1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use |
| 03/18/2009 | EP1292294B1 Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease |
| 03/18/2009 | EP1280420B9 Natural vegetable oil concentrated in unsaponifiable matters as food ingredient |
| 03/18/2009 | EP1231877A4 Transdermal administration of huperzine |
| 03/18/2009 | EP1146789B1 Treating cancers associated with overexpression of her-2/neu |
| 03/18/2009 | EP1095136B1 Cells and animals deficient in protein kinase c epsilon |
| 03/18/2009 | EP1077678A4 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 03/18/2009 | EP1040094B1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 03/18/2009 | EP1037642B1 Modified polysaccharides exhibiting altered biological recognition |
| 03/18/2009 | EP1019714B1 Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of the presence or absence of a lim-kinase gene |
| 03/18/2009 | EP0979090B1 Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine |
| 03/18/2009 | EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |
| 03/18/2009 | EP0872481B1 Depsipeptide derivative, process for production thereof, and novel intermediate therefor |
| 03/18/2009 | EP0741783B1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 03/18/2009 | CN101389760A Peptides effective in the treatment of tumors and other peptides requiring the removal or destruction of cells |
| 03/18/2009 | CN101389632A Spiroketals |
| 03/18/2009 | CN101389631A Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (PDT) |
| 03/18/2009 | CN101389630A Protein kinase inhibitors |
| 03/18/2009 | CN101389629A Indolopyridines as EG5 kinesin modulators |
| 03/18/2009 | CN101389628A Indolopyridines as EG5 kinesin modulators |
| 03/18/2009 | CN101389627A Antibacterial pyrrolopyridines, pyrrolopyrimidines and pyrroloazepines-154 |
| 03/18/2009 | CN101389626A Fused ring heterocycle kinase modulators |
| 03/18/2009 | CN101389623A New salts of an indole derivative and their use in medicine |
| 03/18/2009 | CN101389622A Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 03/18/2009 | CN101389613A Macrocyclic factor viia inhibitors useful as anticoagulants |
| 03/18/2009 | CN101389612A 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
| 03/18/2009 | CN101389611A Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 03/18/2009 | CN101389610A Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 03/18/2009 | CN101389609A Hydantoin based kinase inhibitors |
| 03/18/2009 | CN101389608A 5-HT7 receptor antagonists |
| 03/18/2009 | CN101389607A Substituted arylsulfonamides as antiviral agents |
| 03/18/2009 | CN101389606A Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (CETP) |
| 03/18/2009 | CN101389604A Beta-crystalline form of perindopril arginine salt, method for making same, and pharmaceutical compositions containing same |
| 03/18/2009 | CN101389603A Crystalline form of the arginine salt of perindopril, process for preparing it, and pharmaceutical compositions comprising it |
| 03/18/2009 | CN101389600A Optical isomers of dihydro-2,3-benzodiazepine derivatives, process for their stereoselective synthesis |
| 03/18/2009 | CN101389598A Aliskiren nitrate salt |
| 03/18/2009 | CN101389597A Carbonates of fenicol antibiotics |
| 03/18/2009 | CN101389356A Drug delivery material |
| 03/18/2009 | CN101389352A Agent for treating or preventing digestive ulcer |
| 03/18/2009 | CN101389347A Improved antitumoral treatments |
| 03/18/2009 | CN101389345A Combinatorial methods and compositions for treatment of melanoma. |
| 03/18/2009 | CN101389343A Doxorubicin formulations for anti-cancer use |
| 03/18/2009 | CN101389342A Therapeutic agent for degenerative arthritis |
| 03/18/2009 | CN101389341A Pharmaceutical solution formulations for pressurised metereddose inhalers |
| 03/18/2009 | CN101389340A Combinations of steroids and methylxanthine compounds |
| 03/18/2009 | CN101389339A Therapeutic agent for diabetes |
| 03/18/2009 | CN101389338A 双环杂芳基化合物 Bicyclic heteroaryl compounds |
| 03/18/2009 | CN101389337A Rapamycin derivatives for treating neuroblastoma |
| 03/18/2009 | CN101389336A Hydroxylamines and derivatives for the inhibition of complement activation |
| 03/18/2009 | CN101389335A Thiadiazole compounds and methods of use. |
| 03/18/2009 | CN101389334A Methods to administer epothilone d |
| 03/18/2009 | CN101389333A Stabilized pharmaceutical composition |
| 03/18/2009 | CN101389332A Preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemia reperfusion in stroke |
| 03/18/2009 | CN101389331A Amino acid derivatives of indolinone based protein kinase inhibitors |
| 03/18/2009 | CN101389330A Methods for treating cutaneous lupus using aminoisoindoline compounds |
| 03/18/2009 | CN101389329A Method for increasing blood and/or promoting organic regeneration |
| 03/18/2009 | CN101389328A Compositions and methods for inducing bone growth and inhibiting bone loss |
| 03/18/2009 | CN101389327A Singlet oxygen scavenger, anti-skin-aging agent, anti-wrinkle agent, anti-sagging agent, agent for improving moisture content in the skin, skin-whitening agent, melanin formation inhibitor, nitrogen m |
| 03/18/2009 | CN101389326A Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives |
| 03/18/2009 | CN101389325A Treatment of drug abuse |
| 03/18/2009 | CN101389324A Azaindole inhibitors of aurora kinases |
| 03/18/2009 | CN101389323A Pharmaceutical composition comprising oseltamivir phosphate |
| 03/18/2009 | CN101389322A Use of dha and ara in the preparation of a composition for preventing or treating obesity |